B M Fendly
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Glycosylation and Glycoproteins Research, Cell Adhesion Molecules Research, TGF-β signaling in diseases
Most-Cited Works
- Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.(1997)
- → p185 HER2 Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor(1989)663 cited
- → Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.(1994)644 cited
- → Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies(1993)498 cited
- → p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.(1989)488 cited
- → Humanization of an antibody directed against IgE.(1993)473 cited
- Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.(1994)
- Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product.(1990)
- → Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.(1993)357 cited
- → Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic(1991)295 cited